Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery

about

Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery

Item

http://www.wikidata.org/entity/Q57132503

description

wetenschappelijk artikel

@nl

name

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@en

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@nl

type

Item

label

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@en

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@nl

prefLabel

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@en

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@nl

P1476

Multimodality Treatment of a C ...... r Oncolytic Virus, and Surgery

@en

P2093

Agnija Rasa

http://www.w3.org/2001/XMLSchema#string

Andra Tilgase

http://www.w3.org/2001/XMLSchema#string

Evija Olmane

http://www.w3.org/2001/XMLSchema#string

Jurijs Nazarovs

http://www.w3.org/2001/XMLSchema#string

Linda Brokāne

http://www.w3.org/2001/XMLSchema#string

Pēteris Alberts

http://www.w3.org/2001/XMLSchema#string

Romualds Erdmanis

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?

Relationships between KRAS mutation status and baseline radiographic distribution of disease in patients with stage IV colorectal cancer.

Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study

Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis.

Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.

Oncolytic viruses & their specific targeting to tumour cells.

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.

Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy.

P304

457-465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000492210

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30283278

http://www.w3.org/2001/XMLSchema#string

P921

P932

6167672

http://www.w3.org/2001/XMLSchema#string